Ensysce Biosciences Initiates Live "Ask Me Anything" (AMA) Session Highlighting Growth and Future Plans

Core Viewpoint - Ensysce Biosciences, Inc. is focused on strategic execution plans, regulatory risk mitigation, pipeline prioritization, and the commercial potential of its product PF614 [1] Group 1: Strategic Execution and Community Engagement - The company successfully initiated its live "Ask Me Anything" (AMA) series on March 4, 2024, highlighting its commitment to transparency and open dialogue with the community [1] - A replay of the AMA series is available on the company's website, emphasizing accessibility for stakeholders [1] Group 2: Product Development and Market Potential - Ensysce is pioneering next-generation pain and central nervous system therapeutics aimed at minimizing the risk of abuse and overdose, indicating a strong focus on addressing critical healthcare needs [1]